Covered recipient · General Payments record
FILIPPO MILANO
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$36,286.21
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $11,620.00 | 4 |
| Food and Beverage | $466.84 | 7 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MEDAC PHARMA, INC. | $8,197.79 | 5 |
| Gamida Cell Inc. | $3,522.79 | 2 |
| JAZZ PHARMACEUTICALS INC. | $293.42 | 2 |
| Legend Biotech USA Inc. | $46.38 | 1 |
| Gamida Cell Inc. | $26.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Gamida Cell Inc. | $26.46 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144441115 | CMS |
| Gamida Cell Inc. | $22.79 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144441026 | CMS |
| Gamida Cell Inc. | $3,500.00 | 12/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1144441028 | CMS |
| JAZZ PHARMACEUTICALS INC. | $149.99 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150198727 | CMS |
| JAZZ PHARMACEUTICALS INC. | $143.43 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150198729 | CMS |
| Legend Biotech USA Inc. | $46.38 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131691070 | CMS |
| Medexus Pharma, Inc. | $28.14 | 05/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125822455 | CMS |
| Medexus Pharma, Inc. | $2,040.00 | 06/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125578121 | CMS |
| Medexus Pharma, Inc. | $2,000.00 | 09/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1125577662 | CMS |
| Medexus Pharma, Inc. | $4,080.00 | 09/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134032971 | CMS |
| Medexus Pharma, Inc. | $49.65 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125820040 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.